+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cryptosporidiosis Drug"

Cryptosporidiosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cryptosporidiosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 37 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Cryptosporidiosis is a parasitic infection caused by the protozoan Cryptosporidium. It is a common cause of diarrheal illness in humans and animals. Infectious Diseases Drugs are used to treat this infection. These drugs are typically antibiotics, antifungals, antivirals, and antiparasitics. Commonly used drugs for cryptosporidiosis include nitazoxanide, paromomycin, and azithromycin. The Cryptosporidiosis Drug market is a subset of the Infectious Diseases Drugs market. It is composed of companies that develop, manufacture, and market drugs for the treatment of cryptosporidiosis. These companies are typically large pharmaceutical companies, as well as smaller biotechnology companies. Some companies in the Cryptosporidiosis Drug market include Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., and Johnson & Johnson. Show Less Read more